INSTITUTION'S PROFILE
Amiri Hospital, Sharq, Kuwait.
Publications (9)
Explainable time-to-progression predictions in multiple sclerosis.
Journal: Computer methods and programs in biomedicine
Publication date:
Journal: Computer methods and programs in biomedicine
Publication Year:
Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study.
Journal: PLOS digital health
Publication date:
Journal: PLOS digital health
Publication Year:
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic.
Journal: Journal of neurology
Publication date:
Journal: Journal of neurology
Publication Year:
Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry.
Journal: Journal of neurology, neurosurgery, and psychiatry
Publication date:
Journal: Journal of neurology, neurosurgery, and psychiatry
Publication Year:
Comparative effectiveness in multiple sclerosis: A methodological comparison.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Publication date: 2023
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Publication Year: 2023
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Publication date: 2023
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Publication Year: 2023
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
Journal: JAMA neurology
Publication date: 2023
Journal: JAMA neurology
Publication Year: 2023
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.
Journal: Journal of neurology
Publication date: 2024
Journal: Journal of neurology
Publication Year: 2024
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.
Journal: Journal of medical economics
Publication date: 2023
Journal: Journal of medical economics
Publication Year: 2023